Today is Sunday, Nov. 19, 2017

Department of

Internal Medicine - Jean Elwing Clinical Research

Dr. Jean Elwing -- Clinical Research

I am the principal investigator for several clinical trials in the Division of Pulmonary, Critical Care and Sleep Medicine, evaluating existing and novel therapies for pulmonary arterial hypertension (PAH). Currently, there are 10-12 ongoing phase II and III clinical trials or registries available to PAH patients, with the main focus of examining therapeutics and treatment regimens in hopes to determine the optimal strategies. The UC PH program follows a large cohort of patients affected by PAH. All patients seen in clinic are evaluated for possible participation in clinical trials or registries; the goal is to offer every patient an opportunity to participate in clinical research. Many patients actively participate in clinical trials at some point in their care. The UC PH Program actively collaborates with Cincinnati Children’s Hospital Medical Center and several other divisions at the University of Cincinnati on various research projects. The pulmonary research unit consists of five staff members and two clinical investigators who are focused on pulmonary hypertension. Funding sources include NIH and industry contracts. The program also participates in investigator-initiated projects and often collaborates with trainees who are interested in clinical research.

The HLVI Center for Pulmonary Hypertension is one of several nationally designated Pulmonary Hypertension Association Care Centers, and the only one in Ohio. We have a long-standing commitment to understanding the mechanisms of disease and to clinical research designed to advance the standards of care for our patients.

Challenges of Interpreting Testing